8.31

1.59% 0.13

Intellia Therapeutics Inc (NTLA)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Schlusskurs vom Vortag:

$8.18

Offen:

$8.12

24-Stunden-Volumen:

1.94M

Relative Volume:

0.60

Marktkapitalisierung:

$819.86M

Einnahmen:

$45.97M

Nettoeinkommen (Verlust:

$-508.80M

KGV:

-1.5164

EPS:

-5.48

Netto-Cashflow:

$-382.65M

1W Leistung:

+14.94%

1M Leistung:

-4.81%

6M Leistung:

-47.90%

1J Leistung:

-58.49%

1-Tages-Spanne:

$7.91

$8.33

1-Wochen-Bereich:

$7.15

$8.90

52-Wochen-Spanne:

$5.90

$28.18

Intellia Therapeutics Inc Stock (NTLA) Company Profile

Firmenname

Intellia Therapeutics Inc

Sektor

Healthcare (1154)

Branche

Biotechnology (677)

Telefon

857-285-6200

Adresse

40 ERIE STREET, CAMBRIDGE, MA

Mitarbeiter

598

Twitter

@intelliatweets

Nächster Verdiensttermin

2024-11-07

Neueste SEC-Einreichungen

NTLA's Discussions on Twitter

Vergleichen Sie NTLA mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
NTLA Intellia Therapeutics Inc	8.31	819.86M	45.97M	-508.80M	-382.65M	-5.48
VRTX Vertex Pharmaceuticals Inc	493.84	122.76B	11.02B	-535.60M	-978.00M	-2.20
REGN Regeneron Pharmaceuticals Inc	602.64	61.38B	14.20B	4.41B	3.54B	38.28
ARGX Argen X Se Adr	614.76	36.37B	2.19B	833.04M	-1.28B	12.71
ALNY Alnylam Pharmaceuticals Inc	251.56	30.12B	2.25B	-278.16M	-42.59M	-2.17
ONC Beigene Ltd Adr	244.90	24.70B	3.81B	-644.79M	-669.77M	-6.24

Intellia Therapeutics Inc Stock (NTLA) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-04-21	Hochstufung	Wolfe Research	Peer Perform → Outperform
2025-03-05	Eingeleitet	H.C. Wainwright	Buy
2025-02-28	Herabstufung	Goldman	Neutral → Sell
2025-02-28	Herabstufung	JP Morgan	Overweight → Neutral
2025-01-27	Herabstufung	Morgan Stanley	Overweight → Equal-Weight
2024-02-23	Herabstufung	Goldman	Buy → Neutral
2024-02-15	Eingeleitet	Wolfe Research	Peer Perform
2023-04-13	Eingeleitet	Canaccord Genuity	Buy
2023-03-21	Eingeleitet	Bernstein	Outperform
2023-03-14	Hochstufung	BMO Capital Markets	Market Perform → Outperform
2023-02-01	Eingeleitet	Cantor Fitzgerald	Overweight
2023-01-24	Hochstufung	Citigroup	Sell → Neutral
2023-01-19	Herabstufung	JMP Securities	Mkt Outperform → Mkt Perform
2022-10-11	Eingeleitet	Morgan Stanley	Overweight
2022-09-21	Eingeleitet	JP Morgan	Overweight
2022-09-01	Eingeleitet	Citigroup	Sell
2022-06-17	Eingeleitet	BMO Capital Markets	Market Perform
2022-06-16	Eingeleitet	BofA Securities	Buy
2022-04-28	Eingeleitet	Credit Suisse	Outperform
2022-02-18	Eingeleitet	William Blair	Outperform
2022-02-07	Hochstufung	Oppenheimer	Perform → Outperform
2022-01-31	Eingeleitet	Cowen	Outperform
2022-01-07	Eingeleitet	Piper Sandler	Overweight
2021-10-05	Eingeleitet	Guggenheim	Buy
2021-09-24	Eingeleitet	Stifel	Buy
2021-06-28	Bestätigt	H.C. Wainwright	Buy
2021-06-11	Eingeleitet	H.C. Wainwright	Buy
2021-05-07	Hochstufung	ROTH Capital	Neutral → Buy
2021-05-04	Eingeleitet	RBC Capital Mkts	Outperform
2021-03-04	Eingeleitet	JMP Securities	Mkt Outperform
2020-12-22	Herabstufung	Robert W. Baird	Outperform → Neutral
2020-10-27	Eingeleitet	Truist	Buy
2020-10-14	Eingeleitet	Wells Fargo	Overweight
2020-09-18	Eingeleitet	Goldman	Buy
2020-02-28	Hochstufung	Oppenheimer	Perform → Outperform
2020-02-14	Herabstufung	Wedbush	Outperform → Neutral
2019-11-01	Hochstufung	Raymond James	Mkt Perform → Outperform
2019-07-09	Eingeleitet	Robert W. Baird	Outperform
2019-06-10	Eingeleitet	ROTH Capital	Neutral
2019-05-03	Hochstufung	Wedbush	Neutral → Outperform
2019-04-12	Eingeleitet	Evercore ISI	Outperform
2018-11-02	Herabstufung	Wedbush	Outperform → Neutral
2018-10-29	Eingeleitet	Credit Suisse	Neutral
2018-09-21	Eingeleitet	Raymond James	Mkt Perform
2018-05-15	Hochstufung	Chardan Capital Markets	Neutral → Buy
2018-03-08	Eingeleitet	JMP Securities	Mkt Outperform
2017-11-01	Bestätigt	Jefferies	Buy
2017-06-22	Fortgesetzt	Jefferies	Buy
2017-03-28	Eingeleitet	Chardan Capital Markets	Buy
2016-08-05	Hochstufung	Jefferies	Hold → Buy

Alle ansehen

Intellia Therapeutics Inc Aktie (NTLA) Neueste Nachrichten

03:39 AM

Cathie Wood's Ark Invest Loads Up On Intellia Therapeutics, Offloads Meta Platforms - Benzinga

03:39 AM

Apr 25, 2025

Cathie Wood’s ARK offloads Meta, boosts Intellia stock - Investing.com Australia

Apr 25, 2025

Cathie Wood’s ARK offloads Meta, boosts Intellia stock By Investing.com - Investing.com South Africa

Apr 25, 2025

Is Intellia Therapeutics Inc (NASDAQ:NTLA) A Better Buy Than Others After A -62.53% Fall In This Year? - Marketing Sentinel

Apr 25, 2025

Apr 23, 2025

Insider Sale Alert: Intellia Therapeutics Inc [NTLA] – Is it Time to sell? - knoxdaily.com

Apr 23, 2025

Lawsuit for Investors in shares of Intellia Therapeutics, Inc. (NASDAQ: NTLA) announced by the Shareholders Foundation - PR Newswire

Apr 23, 2025

Apr 21, 2025

Wolfe Research Upgrades Intellia Therapeutics (NTLA) - Nasdaq

Apr 21, 2025

Intellia Therapeutics shares up after Wolfe upgrade - MSN

Apr 21, 2025

Intellia Therapeutics Shares Rise After Upgrade From Wolfe Research - marketscreener.com

Apr 21, 2025

Intellia Therapeutics (NTLA) Surges After Upgrade from Wolfe Research - GuruFocus

Apr 21, 2025

NTLA’s price-to-free cash flow ratio: What it means for investors - uspostnews.com

Apr 21, 2025

Intellia Therapeutics (NTLA) Advances Nex-z in Phase III Trial for ATTRv-PN - GuruFocus

Apr 21, 2025

Intellia Therapeutics (NTLA) Eyes Growth with Gene Editing Advances - GuruFocus

Apr 21, 2025

Intellia Therapeutics (NTLA) Receives Upgrade to Outperform from Wolfe Research | NTLA Stock News - GuruFocus

Apr 21, 2025

Wolverine World Wide, Pacira BioSciences And Other Big Stocks Moving Higher On Monday - Benzinga

Apr 21, 2025

New Horizons in Biomedical CRISPR Gene Editing Market Exploring - openPR.com

Apr 21, 2025

Wolfe Research Upgrades Intellia Therapeutics to Outperform From Peer Perform, Price Target is $21 - marketscreener.com

Apr 21, 2025

Apr 18, 2025

How the (NTLA) price action is used to our Advantage - news.stocktradersdaily.com

Apr 18, 2025

Apr 15, 2025

Intellia Therapeutics, Inc. Sued for Securities Law Violations – Investors Should Contact The ... - Bluefield Daily Telegraph

Apr 15, 2025

Intellia Therapeutics, Inc. Sued for Securities Law - GlobeNewswire

Apr 15, 2025

Apr 14, 2025

Final Deadline Today for the Intellia Therapeutics, Inc. Securit - GuruFocus

Apr 14, 2025

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Intellia Therapeutics, Inc. of Class Action Lawsuit and Upcoming DeadlinesNTLA - PR Newswire

Apr 14, 2025

NTLA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire

Apr 14, 2025

NTLA Investors Have Opportunity to Lead Intellia Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm - Business Wire

Apr 14, 2025

Final Deadline Today for the Intellia Therapeutics, Inc. Securities LawsuitContact the DJS Law Group to Discuss Your RightsNTLA - The Malaysian Reserve

Apr 14, 2025

Class Action Filed Against Intellia Therapeutics, Inc. (NTLA)April 14, 2025 Deadline to JoinContact Levi & Korsinsky - ACCESS Newswire

Apr 14, 2025

FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Intellia Therapeutics - Business Wire

Apr 14, 2025

FINAL REMINDER NTLA DEADLINE: Bronstein, Gewirtz & Grossman LLC Alerts Intellia Therapeutics, Inc. Investors to Participate in the Class Action Lawsuit - markets.businessinsider.com

Apr 14, 2025

NTLA Investors are Reminded of the Final Opportunity to Lead Intellia Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm - The Malaysian Reserve

Apr 14, 2025

NTLA Lawsuit Alert! Class Action Lawsuit Against Intellia Therapeutics Inc. - TipRanks

Apr 14, 2025

Apr 13, 2025

Intellia Therapeutics, Inc. Sued for Securities Law ViolationsContact Levi & Korsinsky Before April 14, 2025 to Discuss Your RightsNTLA - PR Newswire

Apr 13, 2025

NTLA Deadline: NTLA Investors Have Opportunity to Lead Intellia Therapeutics, Inc. Securities Fraud Lawsuit - Morningstar

Apr 13, 2025

FINAL NTLA DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds Intellia Therapeutics, Inc. Investors to Join the Class Action Lawsuit - markets.businessinsider.com

Apr 13, 2025

NTLA Investors Have the Opportunity to Lead the Intellia - GlobeNewswire

Apr 13, 2025

NTLA Investors Have the Opportunity to Lead the Intellia Therapeutics Securities Fraud Lawsuit with Faruqi & Faruqi, LLP - Morningstar

Apr 13, 2025

Apr 12, 2025

NTLA DEADLINE ALERT: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Intellia Therapeutics, Inc. - Bluefield Daily Telegraph

Apr 12, 2025

NTLA DEADLINE ALERT: ROSEN, RECOGNIZED INVESTOR COUNSEL, - GlobeNewswire

Apr 12, 2025

התראת מועד אחרון לתביעה נגד NTLA: רוזן, למשקיעים מוכר, מעודד את משקיעי Intellia Therapeutics, Inc עם הפסדים העולים על 100 אלף דולר, להבטיח ייעוץ לפני המועד האחרון החשוב של 14 באפריל בתביעה ייצוגית בניירות ערך – NTLA - GlobeNewswire Inc.

Apr 12, 2025

Apr 11, 2025

Intellia Therapeutics, Inc. Investors: Please contact the - GlobeNewswire

Apr 11, 2025

NTLA Deadline: Rosen Law Firm Urges Intellia Therapeutics, Inc. (NASDAQ: NTLA) Stockholders with Losses in Excess of $50K to Contact the Firm for Information About Their Rights - Eagle-Tribune

Apr 11, 2025

Apr 10, 2025

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Intellia Therapeutics - PR Newswire

Apr 10, 2025

NTLA INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Stockholders of Intellia Therapeutics, Inc. to Contact the Firm Today! - markets.businessinsider.com

Apr 10, 2025

The Gross Law Firm Notifies Intellia Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming DeadlineNTLA - PR Newswire

Apr 10, 2025

Apr 09, 2025

NTLA DEADLINE: ROSEN, TOP-RANKED INVESTOR COUNSEL, - GlobeNewswire

Apr 09, 2025

NTLA DEADLINE: ROSEN, TOP-RANKED INVESTOR COUNSEL, Encourages Intellia Therapeutics, Inc. - Bluefield Daily Telegraph

Apr 09, 2025

Lost Money on Intellia Therapeutics, Inc. (NTLA)? Join - GlobeNewswire

Apr 09, 2025

Lost Money on Intellia Therapeutics, Inc. (NTLA)? Join Class Action Suit Seeking Recovery – ... - Bluefield Daily Telegraph

Apr 09, 2025

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP - GlobeNewswire

Apr 09, 2025

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Intellia Therapeutics - Morningstar

Apr 09, 2025